X

Trial Profile

A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 05 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Semaglutide (Primary) ; Furosemide; Rosuvastatin; Salcaprozate sodium
Indications Alzheimer's disease; Type 2 diabetes mellitus
Focus Pharmacokinetics
Sponsors Novo Nordisk

Most Recent Events

30 Mar 2021 Results from two trials NCT02845219 and NCT03010475 published in the Clinical Pharmacokinetics
05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
15 Aug 2017 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com